Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fady M Mikhail

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
American Journal of Medical Genetics. Part A|October 28, 2011
Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disordersFady M Mikhail, Edward J Lose, Nathaniel H Robin, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 15, 2013
The recurrent distal 22q11.2 microdeletions are often de novo and do not represent a single clinical entity: a proposed categorization systemFady M Mikhail, Rachel D Burnside, Brooke Rush, et al.
American Journal of Medical Genetics. Part A|August 7, 2007
A previously unrecognized microdeletion syndrome on chromosome 22 band q11.2 encompassing the BCR geneFady M Mikhail, Maria Descartes, Arkadiusz Piotrowski, et al.
Acta Neuropathologica|November 16, 2013
Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesisStephanie N Brosius, Amy N Turk, Stephanie J Byer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 20, 2023
DLG2 intragenic exonic deletions reinforce the link to neurodevelopmental disorders and suggest a potential association with congenital anomalies and dysmorphismYunjia Chen, Ender Karaca, Nathaniel H Robin, et al.
The Journal of Allergy and Clinical Immunology|October 11, 2019
Recurrent microdeletions at chromosome 2p11.2 are associated with thymic hypoplasia and features resembling DiGeorge syndromeJoshua D Bernstock, Arthur H Totten, Abdel G Elkahloun, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 30, 2019
Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC)Fady M Mikhail, Jaclyn A Biegel, Linda D Cooley, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 16, 2016
Clinical relevance of small copy-number variants in chromosomal microarray clinical testingDana Hollenbeck, Crescenda L Williams, Kathryn Drazba, et al.
Frontiers in Oncology|March 16, 2026
Case Report: <i>KMT2A</i> amplification in two adult patients with B-cell acute lymphoblastic leukemiaMin Gao, Yunjia Chen, Kimo Bachiashvili, et al.
Blood|January 27, 2026
Distinct trajectory of measurable residual disease in t(11;14) myeloma treated with quadruplet therapySusan Bal, Gayathri Ravi, Binod Dhakal, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
American Journal of Medical Genetics. Part A|October 28, 2011
Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disordersFady M Mikhail, Edward J Lose, Nathaniel H Robin, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 15, 2013
The recurrent distal 22q11.2 microdeletions are often de novo and do not represent a single clinical entity: a proposed categorization systemFady M Mikhail, Rachel D Burnside, Brooke Rush, et al.
American Journal of Medical Genetics. Part A|August 7, 2007
A previously unrecognized microdeletion syndrome on chromosome 22 band q11.2 encompassing the BCR geneFady M Mikhail, Maria Descartes, Arkadiusz Piotrowski, et al.
Acta Neuropathologica|November 16, 2013
Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesisStephanie N Brosius, Amy N Turk, Stephanie J Byer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 20, 2023
DLG2 intragenic exonic deletions reinforce the link to neurodevelopmental disorders and suggest a potential association with congenital anomalies and dysmorphismYunjia Chen, Ender Karaca, Nathaniel H Robin, et al.
The Journal of Allergy and Clinical Immunology|October 11, 2019
Recurrent microdeletions at chromosome 2p11.2 are associated with thymic hypoplasia and features resembling DiGeorge syndromeJoshua D Bernstock, Arthur H Totten, Abdel G Elkahloun, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 30, 2019
Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC)Fady M Mikhail, Jaclyn A Biegel, Linda D Cooley, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 16, 2016
Clinical relevance of small copy-number variants in chromosomal microarray clinical testingDana Hollenbeck, Crescenda L Williams, Kathryn Drazba, et al.
Frontiers in Oncology|March 16, 2026
Case Report: <i>KMT2A</i> amplification in two adult patients with B-cell acute lymphoblastic leukemiaMin Gao, Yunjia Chen, Kimo Bachiashvili, et al.
Blood|January 27, 2026
Distinct trajectory of measurable residual disease in t(11;14) myeloma treated with quadruplet therapySusan Bal, Gayathri Ravi, Binod Dhakal, et al.
Pageof 8